Modified Citrus Pectin (MCP) is a natural product that is derived from
the peel pith of citrus fruit. It is formulated to:
- Support healthy cellular growth
- Promote normal tissue health
- Support healthy immune function
Pectin is a soluble dietary
fiber composed of galacturonic acid and varying amounts of galactose,
glucose, rhammose, and arabinose. In its natural state, the
galacturonic groups are found esterified. Regular pectin is not
absorbed due to its large size, but it nevertheless plays a key dietary
role in supporting digestive and cardiovascular health. It is also
commonly used as a gelling agent in foods.
PectaSol-C MCP is a special
class of pectin that was developed by Isaac Eliaz, MD, LAc. Dr. Eliaz
has researched and published articles on citrus pectin for over a
decade. MCP is protected by US patents #6,274,566, #6,462,029, and
#7,026,302. PectaSol-C MCP is produced using a scientifically validated
proprietary process that carefully controls both the molecular weight
(MW) and degree of esterification (DE). The specific low molecular
weight size range of PectaSol-C® MCP allows easy absorption into the
bloodstream with the effective range of molecular size and
Research on PectaSol® MCP
Dr. Eliaz developed the
PectalSol® brand as the first modified citrus pectin for human use.
This MCP is designed to be a superior ligand for galectin-3 and
involved extensive preproduction research. A cell culture model using
aberrant prostate cells was used to help determine the optimal MW and
DE by demonstrating cytotoxicity (cell death).* After optimization,
PectaSol® was immediately tested clinically.
PectaSol® is the only brand of
modified citrus pectin that has been validated in human clinical
trials. PectaSol-C® MCP is an integral part of Dr. Eliaz' Healthy
Cellular Support Protocols.
The modification process has
been improved to now produce more pectin molecules in the effective
lower range of molecular weight. The drying process has also been
improved to produce a finer particle size as well, with more than 90%
below 100 microns. This means a better absorbed product.* The new
recent developments have been clinically demonstrated to benefit the
quality of life of advanced state conditions.
product is called PectaSol-C® to differentiate the improved
A clinical trial demonstrated
PectaSol®’s ability to bind and remove toxic heavy metals and while not
affecting essential minerals.* A recent study reported that PectaSol
significantly decreased lead levels in children (ages 5 to 12) who
suffered from severe lead poisoning.*
MCP contains polysaccharide components that researchers have shown
shift T cell balance to favor Natural Killer (NK) cell activation.